• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

金色分枝杆菌和耻垢分枝杆菌对诺氟沙星的积累

Accumulation of norfloxacin by Mycobacterium aurum and Mycobacterium smegmatis.

作者信息

Williams K J, Chung G A, Piddock L J

机构信息

Department of Infection, The Medical School, University of Birmingham, Edgbaston, United Kingdom.

出版信息

Antimicrob Agents Chemother. 1998 Apr;42(4):795-800. doi: 10.1128/AAC.42.4.795.

DOI:10.1128/AAC.42.4.795
PMID:9559785
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC105544/
Abstract

The modified fluorescence method was used to determine the accumulation of norfloxacin by Mycobacterium aurum A+ and Mycobacterium smegmatis mc(2)155. By using an exogenous norfloxacin concentration of 10 microg/ml, a steady-state concentration (SSC) of 160 to 180 ng of norfloxacin/mg of cells was obtained for M. aurum, and an SSC of 120 to 140 ng of norfloxacin/mg of cells obtained for M. smegmatis. For both species of mycobacteria, the SSC was achieved within 5 min. The silicon oil method was investigated and gave higher SSCs than the modified fluorescence method. Further studies on the mechanism of norfloxacin accumulation by M. aurum were performed. An increase in the pH of the wash buffer from 7.0 to 9.0 did not significantly affect the final SSC obtained. Accumulation was nonsaturated over a norfloxacin concentration range of 0 to 100 microg/ml, and the proton motive force inhibitor 2,4-dinitrophenol (1 and 2 mM), whether it was added before or after norfloxacin was added, had no effect on the final SSC obtained. 2,4-Dinitrophenol also had no effect on norfloxacin accumulation by M. smegmatis. Furthermore, norfloxacin accumulation by M. aurum was unaffected by the presence of either Tween 80 or subinhibitory concentrations of ethambutol in the growth medium. Therefore, it is proposed that norfloxacin accumulation by mycobacteria occurs by simple, energy-independent diffusion.

摘要

采用改良荧光法测定了金色分枝杆菌A+和耻垢分枝杆菌mc(2)155对诺氟沙星的积累情况。在外源诺氟沙星浓度为10微克/毫升的情况下,金色分枝杆菌的诺氟沙星稳态浓度(SSC)为160至180纳克/毫克细胞,耻垢分枝杆菌的SSC为120至140纳克/毫克细胞。对于这两种分枝杆菌,5分钟内即可达到SSC。对硅油法进行了研究,其得到的SSC高于改良荧光法。对金色分枝杆菌积累诺氟沙星的机制进行了进一步研究。洗涤缓冲液的pH从7.0增加到9.0对最终获得的SSC没有显著影响。在0至100微克/毫升的诺氟沙星浓度范围内,积累是非饱和的,质子动力抑制剂2,4-二硝基苯酚(1和2毫摩尔),无论在添加诺氟沙星之前还是之后添加,对最终获得的SSC都没有影响。2,4-二硝基苯酚对耻垢分枝杆菌积累诺氟沙星也没有影响。此外,生长培养基中吐温80或亚抑制浓度的乙胺丁醇的存在对金色分枝杆菌积累诺氟沙星没有影响。因此,提出分枝杆菌积累诺氟沙星是通过简单且不依赖能量的扩散发生的。

相似文献

1
Accumulation of norfloxacin by Mycobacterium aurum and Mycobacterium smegmatis.金色分枝杆菌和耻垢分枝杆菌对诺氟沙星的积累
Antimicrob Agents Chemother. 1998 Apr;42(4):795-800. doi: 10.1128/AAC.42.4.795.
2
Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis.金色分枝杆菌、耻垢分枝杆菌和结核分枝杆菌对利福平的摄取
J Antimicrob Chemother. 2000 Feb;45(2):159-65. doi: 10.1093/jac/45.2.159.
3
Intracellular accumulation of norfloxacin in Mycobacterium smegmatis.诺氟沙星在耻垢分枝杆菌中的细胞内积累。
Antimicrob Agents Chemother. 1995 Nov;39(11):2466-71. doi: 10.1128/AAC.39.11.2466.
4
Accumulation of KRM-1648 by Mycobacterium aurum and Mycobacterium tuberculosis.金色分枝杆菌和结核分枝杆菌对KRM-1648的摄取。
J Antimicrob Chemother. 2000 May;45(5):681-4. doi: 10.1093/jac/45.5.681.
5
Evaluation of the intracellular accumulation of fluoroquinolones in mycobacteria by fluorometric assays.荧光分析法评价分枝杆菌内氟喹诺酮类药物的蓄积。
Int J Mycobacteriol. 2020 Jan-Mar;9(1):34-38. doi: 10.4103/ijmy.ijmy_194_19.
6
Accumulation of norfloxacin by Bacteroides fragilis.脆弱拟杆菌对诺氟沙星的蓄积
Antimicrob Agents Chemother. 2000 Sep;44(9):2361-6. doi: 10.1128/AAC.44.9.2361-2366.2000.
7
Active efflux of fluoroquinolones in Mycobacterium smegmatis mediated by LfrA, a multidrug efflux pump.耻垢分枝杆菌中由多药外排泵LfrA介导的氟喹诺酮类药物主动外排
J Bacteriol. 1996 Jul;178(13):3791-5. doi: 10.1128/jb.178.13.3791-3795.1996.
8
Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis.耻垢分枝杆菌中流出泵介导的固有耐药性。
Antimicrob Agents Chemother. 2004 Jul;48(7):2415-23. doi: 10.1128/AAC.48.7.2415-2423.2004.
9
Rapid drug susceptibility testing of mycobacteria in tissue culture medium.在组织培养基中对分枝杆菌进行快速药敏试验。
Antimicrob Agents Chemother. 1983 Aug;24(2):268-72. doi: 10.1128/AAC.24.2.268.
10
The draft genome of Mycobacterium aurum, a potential model organism for investigating drugs against Mycobacterium tuberculosis and Mycobacterium leprae.金色分枝杆菌的基因组草图,一种用于研究抗结核分枝杆菌和麻风分枝杆菌药物的潜在模式生物。
Int J Mycobacteriol. 2015 Sep;4(3):207-16. doi: 10.1016/j.ijmyco.2015.05.001. Epub 2015 Jun 4.

引用本文的文献

1
Distribution of fluoroquinolones in the two aqueous compartments of .氟喹诺酮类药物在……的两个水相组分中的分布。 (原文不完整,翻译只能到这里)
Biochem Biophys Rep. 2020 Nov 13;24:100849. doi: 10.1016/j.bbrep.2020.100849. eCollection 2020 Dec.
2
Transformation of the antibacterial agent norfloxacin by environmental mycobacteria.环境分枝杆菌对抗菌剂诺氟沙星的转化作用。
Appl Environ Microbiol. 2006 Sep;72(9):5790-3. doi: 10.1128/AEM.03032-05.

本文引用的文献

1
Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: selective targeting of gyrase or topoisomerase IV by quinolones.司帕沙星对肺炎链球菌中DNA回旋酶的靶向作用:喹诺酮类药物对回旋酶或拓扑异构酶IV的选择性靶向作用
Antimicrob Agents Chemother. 1997 Feb;41(2):471-4. doi: 10.1128/AAC.41.2.471.
2
Proton-dependent multidrug efflux systems.质子依赖型多药外排系统
Microbiol Rev. 1996 Dec;60(4):575-608. doi: 10.1128/mr.60.4.575-608.1996.
3
ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype.肺炎链球菌DNA拓扑异构酶IV的ParC亚基是氟喹诺酮类药物的主要作用靶点,并与DNA回旋酶A亚基协同形成耐药表型。
Antimicrob Agents Chemother. 1996 Oct;40(10):2252-7. doi: 10.1128/AAC.40.10.2252.
4
Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra.结核分枝杆菌H37Ra实验室筛选的耐氟喹诺酮突变体中的gyrase突变。
Antimicrob Agents Chemother. 1996 Aug;40(8):1768-74. doi: 10.1128/AAC.40.8.1768.
5
Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli.喹诺酮耐药性大肠埃希菌临床分离株中parC基因突变的检测
Antimicrob Agents Chemother. 1996 Feb;40(2):491-3. doi: 10.1128/AAC.40.2.491.
6
gyrA of ofloxacin-resistant clinical isolates of Mycobacterium tuberculosis from Hong Kong.
J Antimicrob Chemother. 1996 May;37(5):1032-4. doi: 10.1093/jac/37.5.1032.
7
Active efflux of fluoroquinolones in Mycobacterium smegmatis mediated by LfrA, a multidrug efflux pump.耻垢分枝杆菌中由多药外排泵LfrA介导的氟喹诺酮类药物主动外排
J Bacteriol. 1996 Jul;178(13):3791-5. doi: 10.1128/jb.178.13.3791-3795.1996.
8
High-throughput screen for detecting antimycobacterial agents.用于检测抗分枝杆菌药物的高通量筛选
Antimicrob Agents Chemother. 1995 Oct;39(10):2235-8. doi: 10.1128/AAC.39.10.2235.
9
Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?青霉素和其他β-内酰胺类抗生素可用于治疗结核病吗?
Antimicrob Agents Chemother. 1995 Dec;39(12):2620-4. doi: 10.1128/AAC.39.12.2620.
10
Intracellular accumulation of norfloxacin in Mycobacterium smegmatis.诺氟沙星在耻垢分枝杆菌中的细胞内积累。
Antimicrob Agents Chemother. 1995 Nov;39(11):2466-71. doi: 10.1128/AAC.39.11.2466.